Changes in Medicaid Enrollment Among Adult Survivors of Childhood Cancer After Medicaid Expansion: A Report From the Childhood Cancer Survivor Study Renal cell carcinomas (RCCs) of variant histology, ...
PD-1 blocking treatment may convert TAMs from tumor-promoting to tumor-fighting, improving outcomes in metastatic clear cell kidney cancer. Higher levels of CD163-positive TAMs are linked to better ...
Hosted on MSN
Stem cell scientists unlock blueprint for lab-grown kidney cells with preclinical value
In the lab, it's easier to grow simple balls of cells than complex asymmetrical structures with two distinct ends—like the one million filtering units—nephrons—that make up a human kidney. But new ...
University of Florence–led investigators report that estrogen-regulated renal progenitor cells shape pregnancy adaptation in mice with failure of estrogen receptor alpha signaling precipitating ...
CD45 + C1q + CCR8+ cells may serve as a biomarker for kidney disease severity and progression risk, reflecting inflammation and fibrosis. Elevated levels of these cells correlate with serum creatinine ...
Enabling patients to generate CAR T-cells internally could cut kidney cancer therapy costs, explained Dr. Wayne Marasco of Dana-Farber Cancer Institute. In vivo CAR T-cell therapy could drastically ...
A study provides new insight into how damaged cells interact within disease-promoting microenvironments following acute kidney injury, or AKI. Researchers used a cutting-edge tool, called seqFISH, ...
Chronic kidney disease (CKD) affects more than 10% of the global population and is expected to become the fifth leading cause of death worldwide within the next two decades. Perhaps surprisingly, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results